Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00565721 | A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis | completed | Phase 2 | 33 | GE HealthcareINDUSTRY | 1 | Aug 18, 2014 | clinicaltrials |
| NCT00372788 | AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen | completed | Phase 2 | 88 | AstraZenecaINDUSTRY | 3 | Aug 13, 2014 | clinicaltrials |
| NCT02215356 | Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT01236716 | Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung(C-TONG1002) | completed | Phase 2 | 126 | Chinese Society of Lung CancerOTHER | 1 | Aug 6, 2014 | clinicaltrials |
| NCT00193921 | Chemoradiotherapy in Patients With Localised Lung Cancer | completed | Phase 2 | 82 | Trans Tasman Radiation Oncology GroupOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT02191059 | Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer | unknown | Phase 2 | 60 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT00504725 | Ketamine In Thoracic Surgery (KITS) Trial(KITS) | completed | Phase 2 | 40 | Duke UniversityOTHER | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00373204 | Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | terminated | Phase 2 | 50 | Pharmacyclics LLC.INDUSTRY | 4 | Jul 24, 2014 | clinicaltrials |
| NCT01913067 | Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC(CRANIAL) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 1 | Jul 24, 2014 | clinicaltrials |
| NCT01514877 | Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Zhejiang Cancer HospitalOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00796549 | BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients | completed | Phase 2 | 70 | Boehringer IngelheimINDUSTRY | 1 | Jul 22, 2014 | clinicaltrials |
| NCT00545948 | Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer(TOP0703) | terminated | Phase 2 | 31 | Duke UniversityOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT00415818 | Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 148 | TransgeneINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT01491633 | Dasatinib in Advanced Squamous Cell Lung Cancer | terminated | Phase 2 | 5 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT01362296 | An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer | completed | Phase 2 | 134 | GlaxoSmithKlineINDUSTRY | 8 | Jul 11, 2014 | clinicaltrials |
| NCT00661778 | A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01240447 | Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients | completed | Phase 2 | 7 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01996332 | A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 1,805 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT02157116 | Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 13 | Duke UniversityOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00145418 | Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer | terminated | Phase 2 | 15 | Oncology Specialists, S.C.OTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT00620971 | Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC | completed | Phase 2 | 77 | Hellenic Oncology Research GroupOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00118235 | Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00528775 | Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages | terminated | Phase 2 | 6 | Roswell Park Cancer InstituteOTHER | 1 | Jun 10, 2014 | clinicaltrials |
| NCT00544648 | Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC | terminated | Phase 1 / Phase 2 | 13 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection | completed | Phase 2 | 70 | GE HealthcareINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00976677 | Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT01654081 | A Protocol of Irinotecan for Carcinoma of the Lung | withdrawn | Phase 2 | 0 | Susanne ArnoldOTHER | 0 | May 30, 2014 | clinicaltrials |
| NCT00084487 | Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy | terminated | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00368927 | Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | completed | Phase 2 | 61 | National Cancer Institute (NCI)NIH | 2 | May 23, 2014 | clinicaltrials |
| NCT02146118 | A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 2 | 42 | MedicalLogicINDUSTRY | 1 | May 23, 2014 | clinicaltrials |
| NCT00323362 | Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer | terminated | Phase 2 | 17 | Rutgers, The State University of New JerseyOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00614484 | Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer | terminated | Phase 1 / Phase 2 | 28 | Loma Linda UniversityOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00182689 | Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 89 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00313690 | Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer | withdrawn | Phase 1 / Phase 2 | 0 | University of Southern CaliforniaOTHER | 0 | May 21, 2014 | clinicaltrials |
| NCT00778167 | Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT01004250 | A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer | completed | Phase 2 | 109 | Eli Lilly and CompanyINDUSTRY | 5 | May 21, 2014 | clinicaltrials |
| NCT01362400 | A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 226 | Infinity Pharmaceuticals, Inc.INDUSTRY | 6 | May 19, 2014 | clinicaltrials |
| NCT00066742 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT02139579 | Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer | unknown | Phase 2 | 24 | Sun Yat-sen UniversityOTHER | 0 | May 15, 2014 | clinicaltrials |
| NCT00079040 | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | May 14, 2014 | clinicaltrials |
| NCT00773955 | R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | May 12, 2014 | clinicaltrials |
| NCT01471197 | Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer | terminated | Phase 2 | 9 | Bristol-Myers SquibbINDUSTRY | 5 | May 12, 2014 | clinicaltrials |
| NCT00049218 | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 56 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00103363 | Sputum Cytology in Screening Heavy Smokers For Lung Cancer | completed | Phase 2 | 3,270 | University of Colorado, DenverOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT00005037 | Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 51 | Fox Chase Cancer CenterOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT00406302 | Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 41 | Wolfgang HilbeOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT01969955 | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT02044601 | Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT00616109 | Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC | completed | Phase 2 | 16 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Aug 18, 2014source: clinicaltrials